TXONE-NETWORKS
25.4.2024 09:05:30 CEST | Business Wire | Press release
TXOne Networks, a leading company in the field of cyber-physical systems (CPS) security, will be presenting its new CPS security platform during the Hannover Messe from 22nd to 26th April 2024 at stand B06 in hall 16: SageOne, which means Wise Man Number One. This central management console provides an overview of the CPS attack surface of the OT environment.
All three TXOne product lines can be centrally controlled, namely Stellar for endpoint protection, Element for security inspection and Edge for network defense. The platform offers integrated OT security across the entire lifecycle of the objects to be protected and enables reliable detection and response to threats.
SageOne essentially covers three main pillars:
- CPS Attack Surface Management: Visibility is a cornerstone for cybersecurity. A clear view of the overall security posture helps identify security focal points in an OT environment. SageOne focuses on operational security by honing in on assets and illuminating the security information of various controls.
- Integrated Lifecycle Protection: Centralized management simplifies cybersecurity governance and achieves collaborative defense. As an abstraction layer, SageOne streamlines the contextualization and consolidation of data across various products. It offers a tailored, task-oriented console designed specifically for executives, security personnel, and plant leaders.
- CPS Threat Detection & Response: Properly handling known threats is absolutely crucial. Coping with unknown threats is equally important. SageOne compiles all security insights from multiple solutions and scouts for potential risks in order to enable early caution and response when needed.
To achieve this goal, the platform includes the following key components:
- Threat intelligence means collecting, analysing and applying knowledge about potential and existing threats against a CPS. The TXOne Threat Research department carries out a large number of investigations into vulnerabilities in Industrial Control Systems (ICS) devices and protocols. It analyses malware and ransomware in connection with Operational Technology (OT) threats. This information can also come from a variety of other sources: Publicly available data, industry reports and private sector information.
- Behaviour-based AI analytics engines use artificial intelligence to monitor and analyse the behaviour of users, devices and systems within a CPS. This advanced analytics engine learns the normal behavioural patterns of these entities and can detect unusual activity or anomalies that could indicate a security threat.
- The Compliance Framework provides a structured approach to compliance with relevant safety standards and regulations. It includes policies, procedures and controls to ensure that every system complies with legal requirements, industry standards and security best practices.
- The Data Visualiser is a tool that transforms complex safety data and metrics into an easy-to-understand visual form. Using diagrams, graphs and network maps, security professionals can recognise patterns and trends as well as anomalies more quickly.
- The Ecosystem Integrator helps to seamlessly integrate different tools and technologies. This includes standardising data formats, promoting the interoperability of different systems and creating a coherent security architecture that covers the entire ecosystem. This enables security forces to obtain a standardised overview of the security situation, automate processes and respond more effectively to threats.
SageOne focuses on the analysis of unexpected behaviour and unknown threats. Suspicious events can be identified by comparing endpoint and network telemetry within the OT-native XDR (Extended Detection and Response) engine. The platform thus combines advanced technologies with a user-friendly interface to ensure the protection of critical infrastructures. To achieve reliable CPS attack surface management, SageOne also offers Asset Centric Visibility to provide full visibility of any device on the network. In addition, the analysis of the attack surface is prioritised and recommendations are made.
To enable a rapid response to threats, SageOne can issue early warnings of suspicious behaviour in the network as part of CPS Threat Detection & Response Orchestration using cross-telemetry analysis.
In addition, Integrated Lifecycle Protection protects devices and systems over their entire service life. The centralised management of the security solutions and the unified defence under one roof contribute to this, resulting in high cost efficiency. With SageOne, TXOne Networks emphasises its commitment to the security and reliability of CPS and continuously drives the development of OT security.
Visit TXOne Networks at the Hannover Messe from 22nd to 26th April 2024 at booth B06 in hall 16.
Follow TXOne Networks on the blog, Twitter and LinkedIn.
About TXOne Networks
TXOne Networks provides OT security products that ensure the reliability and security of industrial control systems and operational technology environments through the OT Zero Trust methodology. TXOne Networks works with both leading industrial manufacturers and critical infrastructure operators to develop practical and business-friendly approaches to OT defence. TXOne Networks offers both network and endpoint-based products to secure OT networks and mission-critical devices in real-time and with high security depth. www.txone.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240420367607/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
